ESTRO 2025 - Abstract Book

S1155

Clinical – Lower GI

ESTRO 2025

No significant associations were identified for cCR or LRR.

Conclusion: Important variability exists in the delivery of RT boost for primary tumour in LARC. This review highlights the association between certain technical parameters and improved oncological outcomes, laying the groundwork for developing consensus guidelines on RT rectal boost.

Keywords: Rectal cancer, RT boost, Meta-analysis

References: 1. Glynne-Jones, R., et al., Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 2017. 28 (suppl_4): p. iv22-iv40. 2. Garcia-Aguilar, J., et al., Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy. J Clin Oncol, 2022. 40 (23): p. 2546-2556. 3. Burbach, J.P.M., et al., Impact of radiotherapy boost on pathological complete response in patients with locally advanced rectal cancer: A systematic review and meta-analysis. Radiotherapy and Oncology, 2014. 113 (1): p. 1-9.